The Enterprise Value as of June 2026 (TTM) for Inhibitor Therapeutics, Inc. (INTI) is 13.44M

According to Inhibitor Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 13.44M. This represents a change of 66.84% compared to the average of 8.05M of the last 4 quarters.

Inhibitor Therapeutics, Inc. (INTI) Historical Enterprise Value (quarterly & annually)

How has INTI Enterprise Value performed in the past?

The mean historical Enterprise Value of Inhibitor Therapeutics, Inc. over the last ten years is 34.67M. The current 13.44M Enterprise Value has changed 3.78% with respect to the historical average. Over the past ten years (40 quarters), INTI's Enterprise Value was at its highest in in the September 2017 quarter at 154.34M. The Enterprise Value was at its lowest in in the June 2023 quarter at -3737511.00.

Inhibitor Therapeutics, Inc. (INTI) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Inhibitor Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Inhibitor Therapeutics, Inc. (INTI) Average Enterprise Value

How has INTI Enterprise Value performed in the past?

The current Enterprise Value of Inhibitor Therapeutics, Inc. (INTI) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Inhibitor Therapeutics, Inc. (INTI) Enterprise Value vs. Peers

How is INTI’s Enterprise Value compared to its peers?

Inhibitor Therapeutics, Inc.’s Enterprise Value is greater than LianBio (8.07M), greater than Oxford BioDynamics Plc (7.56M), less than Devonian Health Group Inc. (40.24M), greater than Chimeric Therapeutics Limited (410.43K), greater than Quantum Genomics S.A. (7.34M), greater than Curative Biotechnology, Inc. (10.89M), greater than Nymox Pharmaceutical Corporation (9.10M), greater than BetterLife Pharma Inc. (12.22M), greater than PharmaTher Holdings Ltd. (4.67M), greater than Nass Valley Gateway Ltd. (12.82M),

Build a custom stock screener for Inhibitor Therapeutics, Inc. (INTI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Inhibitor Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Inhibitor Therapeutics, Inc. (INTI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Inhibitor Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.